Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

Diabetes

Volumn 43, Issue 3, 1994, Pages 384-388

  Marre, Michel ^a,b   Bernadet, Pauline ^c   Gallois, Yves ^b   Savagner, Frederique ^e   Guyene, Tham Tam ^c   Hallab, Magid ^a   Cambien, François ^c   Passa, Philippe ^d   Alhenc Gelas, François ^c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Universite d'Angers   (France)

^c INSERM   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e Hospital Saint Louis ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME BLOOD LEVEL; FEMALE; GENETIC MARKER; GENOTYPE; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

EID: 0028121082     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.3.384     Document Type: Article

References (30)

1. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 28:590-96, 1985
2. Krowlewski AJ, Warram JH, Rand LI, Kahn CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-98, 1987
3. Zatz R, Brenner BM: Pathogenesis of diabetic microangiopathy; the hemodynamic view. Am J Med 80:443-53, 1986
4. Erdos EG: Angiotensin I-converting enzyme and the changes in our concepts through the years. Hypertension 16:363-70, 1990
5. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P: Distribution of plasma angiotensin I-converting enzyme in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med 117:33-39, 1991
6. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J, Bloch C: Familial resemblance of plasma angiotensin I converting enzyme level: the Nancy study. Am J Hum Genet 43:774-80, 1988
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-46, 1990
8. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel Ph, Alhenc-Gelas F, Soubrier F: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-44, 1992
9. Lieberman J, Sastre A: Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 93:825-26, 1980
10. Hallab M, Bled F, Ebran JM, Suraniti S, Girault A, Fressinaud Ph, Marre M: Elevated serum angiotensin converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29:82-85, 1992
11. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC: Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9:85-95, 1985-86
12. Menard J, Guyenne TT, Corvol P, Pau B, Simon D, Roncucci R: J Hypertens 3 (Suppl.):275-78, 1985
13. Alhenc-Gelas F, Weare JA, Johnson RL Jr, Erdos EG: Measurements of human converting enzyme level by direct radioimmunoassay. J Lab Clin Med 101:86-96, 1983
14. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertin/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl-carboxy peptidose 1). Nucleic Acids Res 20:1433, 1992
15. Pirart J: Diabete et complications dégénératives: présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. Diabete Metab 3:97-107, 9173-82, 245-56, 1977
16. Franken AAM, Derxk FHM, Man in't Veld, Hop WCJ, Van Rens GH, Peperkamp E, deJong PTVM, Schalekamp MADH: High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 71:1008-15, 1990
17. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationship in diabetic nephropathy. J Clin Invest 74:1143-55, 1984
18. Forsblom CM, Groop PH, Ekstrand A, Groop LC: Predictive value of microalbuminuria in insulin-dependent diabetes of long duration. Br Med J 305:1051-53, 1992
19. Lane PH, Steffes MW, Mauer M: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 41:581-86, 1992
20. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T: Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes 36:205-209, 1987
21. Vane GR: Sites of conversion of angiotensin I. In Hypertension. Genest J, Koine E, Eds. Berlin, Springer Verlag, 1972, p. 523-32
22. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Tripoddo NC: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366-72, 1977
23. Mayfield RK, Margolius HS, Levine JH, Wohltmann HJ, Lokowolt LB, Colwell JA: Urinary kallikrein excretion in insulin dependent diabetes mellitus and its relationship to glycaemic control. J Clin Endocrinol Metab 59:278-86, 1984
24. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I converting enzyme in human circulatory mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40, 1993
25. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P, Cambien F: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341:991-92, 1993
26. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Envoldsen A: Albuminuria reflects widespread vascular damage; the Steno hypothesis. Diabetologia 32:219-26, 1989
27. Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297:1092-95, 1988
28. Bjorcks S, Mulec H, Johnson SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-43, 1992
29. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud Ph, Marre M: Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin-dependent diabetes. Br Med J 306:3175-82, 1993
30. Mangili R, Bending JJ, Scott G, Lil K, Gupta A, Viberti GC: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318: 146-50, 1988